The included studies consisted of randomized controlled trials (RCTs), clinical trials, and observational studies that evaluated the effects of vitamin E on liver enzymes (ALT and AST) and histological outcomes (steatosis, inflammation, and fibrosis) in adults diagnosed with NAFLD or NASH. The gene discussed is GPT; the disease is steatosis.